Hubert Chen

Hubert Chen currently serves as the Chief Medical Officer at Attovia Therapeutics since March 2024. Previously, Hubert Chen was the Senior Vice President of Clinical Development at Krystal Biotech, Inc. from October 2021 to March 2024. Hubert Chen's extensive experience at Genentech from 2011 to September 2021 includes roles such as Principal Medical Director, Senior Medical Director, Medical Director, and Associate Medical Director. Prior to Genentech, Hubert Chen held academic and clinical positions at UCSF Medical Center from 2002 to 2011, where responsibilities included Assistant Professor of Medicine and Clinical Instructor. Hubert Chen completed an Internal Medicine Residency at Stanford University Medical Center from 1998 to 2001. Educational qualifications include an MD from Stanford University School of Medicine, an MPH in Quantitative Methods from Harvard T.H. Chan School of Public Health, and a BA in Molecular Biology from Pomona College.